EIF2A and adenocarcinoma: Early in situ/minimally invasive lesions (AIS/MIA) had the lowest levels of p-eIF2α, followed by predominantly in situ tumors showing clear areas of invasion (lepidic-predominant adenocarcinoma), and then the invasive-predominant groups (Fig. 1d).